{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:42Z","timestamp":1793946642959,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012529","name":"Insamlingsstiftelsen Diabetes Wellness Network Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"The Paulo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004325","name":"Signe and Ane Gyllenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eclinm.2026.104042","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:13:06Z","timestamp":1783005186000},"page":"104042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial"],"prefix":"10.1016","volume":"97","author":[{"given":"Jeanha","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ioannidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Robert-Nicoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi H.","family":"Pietil\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"R\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric V.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-030X","authenticated-orcid":false,"given":"Tore","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104042_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.02.001","article-title":"Towards mesoporous silica as a pharmaceutical treatment for obesity - impact on lipid digestion and absorption","volume":"173","author":"May","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104042_bib2","article-title":"Entrapping digestive enzymes with engineered mesoporous silica particles reduces metabolic risk factors in humans","volume":"9","author":"Waara","year":"2020","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104042_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2217\/nnm.13.138","article-title":"Large pore mesoporous silica induced weight loss in obese mice","volume":"9","author":"Kupferschmidt","year":"2014","journal-title":"Nanomedicine (Lond)"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104042_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/nnm-2019-0262","article-title":"Mesoporous silica with precisely controlled pores reduces food efficiency and suppresses weight gain in mice","volume":"15","author":"Rinde","year":"2020","journal-title":"Nanomedicine (Lond)"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104042_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240030","article-title":"Oral intake of mesoporous silica is safe and well tolerated in male humans","volume":"15","author":"Hagman","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nnm-2021-0235","article-title":"Engineered mesoporous silica reduces long-term blood glucose, HbA1c, and improves metabolic parameters in prediabetics","volume":"17","author":"Baek","year":"2022","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.eclinm.2026.104042_bib7","series-title":"Diabetes atlas","author":"Federation","year":"2025"},{"key":"10.1016\/j.eclinm.2026.104042_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-019-0080-0","article-title":"Global epidemiology of prediabetes - present and future perspectives","volume":"5","author":"Hostalek","year":"2019","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.eclinm.2026.104042_bib9","series-title":"Diagnosis and management of type 2 diabetes","year":"2020"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104042_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jech-2019-213415","article-title":"Adherence to healthy lifestyles and incidence of diabetes and mortality among individuals with diabetes: a systematic review and meta-analysis of prospective studies","volume":"74","author":"Schlesinger","year":"2020","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12889-022-12885-8","article-title":"Facilitators and barriers for lifestyle change in people with prediabetes: a meta-synthesis of qualitative studies","volume":"22","author":"Skoglund","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104042_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3122\/jabfm.2022.04.210485","article-title":"Metformin prescription rates for patients with prediabetes","volume":"35","author":"Hughes","year":"2022","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.eclinm.2026.104042_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.975912","article-title":"Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review, meta-analysis and meta-regression of randomized controlled trials","volume":"13","author":"Nabrdalik","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104042_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104042_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/JPR.S134745","article-title":"A systematic review of sex differences in the placebo and the nocebo effect","volume":"10","author":"Vambheim","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.eclinm.2026.104042_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnins.2019.00160","article-title":"Does sex\/gender play a role in placebo and nocebo effects? Conflicting evidence from clinical trials and experimental studies","volume":"13","author":"Enck","year":"2019","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104042_bib17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1017\/S0007114513003875","article-title":"Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women","volume":"111","author":"Sanchez","year":"2014","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104042_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/j.1550-8528.1999.tb00415.x","article-title":"Physical activity and low-fat diet: is it enough to maintain weight stability in the reduced-obese individual following weight loss by drug therapy and energy restriction?","volume":"7","author":"Doucet","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.eclinm.2026.104042_bib19","doi-asserted-by":"crossref","DOI":"10.5402\/2013\/723250","article-title":"Sex differences in the effects of mental work and moderate-intensity physical activity on energy intake in young adults","volume":"2013","author":"Perusse-Lachance","year":"2013","journal-title":"ISRN Nutr"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104042_bib20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104042_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/obr.12241","article-title":"Effectiveness of weight loss interventions--is there a difference between men and women: a systematic review","volume":"16","author":"Williams","year":"2015","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104042_bib22","article-title":"Gamma-glutamyl transferase as a diagnostic marker of metabolic syndrome","volume":"15","author":"Naidu","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13098-023-01200-z","article-title":"Metabolic syndrome and transaminases: systematic review and meta-analysis","volume":"15","author":"Raya-Cano","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104042_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41366-024-01664-7","article-title":"Assessing the evidence for health benefits of low-level weight loss: a systematic review","volume":"49","author":"Dhar","year":"2025","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104042_bib25","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/dc06-0560","article-title":"Effect of weight loss with lifestyle intervention on risk of diabetes","volume":"29","author":"Hamman","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104042_bib26","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1111\/dom.16561","article-title":"Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: a meta-analysis and meta-regression of 44 randomized controlled trials","volume":"27","author":"Diallo","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104042_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr Physiol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13300-024-01660-0","article-title":"Post hoc analysis of SURPASS-1 to -5: efficacy and safety of tirzepatide in adults with type 2 diabetes are independent of baseline characteristics","volume":"16","author":"De Block","year":"2025","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/dom.15309","article-title":"Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China","volume":"26","author":"Ji","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","article-title":"Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial","volume":"22","author":"Sandsdal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104042_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4239\/wjd.v6.i1.109","article-title":"beta-cell dysfunction: its critical role in prevention and management of type 2 diabetes","volume":"6","author":"Saisho","year":"2015","journal-title":"World J Diabetes"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:50:10Z","timestamp":1793944210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S2589537026002956"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104042","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104042"}}